Verticals / Pharma, medtech & health distribution / NovaBay Pharmaceuticals
NP
NovaBay Pharmaceuticals
—
Latest disclosed NPS
no score published
0
NPS entries
0 with a number
2024
Years covered
1 entries in all
In their words
“NovaBay Pharmaceuticals launched a direct-to-consumer programme targeting its loyal customer base to enhance retention.”
NPS disclosures (0)
No NPS disclosures yet.
Retention disclosures (1)
23 Apr 2024
Retention
NovaBay Pharmaceuticals launched a direct-to-consumer programme targeting its loyal customer base to enhance retention.
— reported by markets.ft.com · 23 Apr 2024 · NI-0B2AB38
markets.ft.com ↗Lighthouse companies in Pharma, medtech & health distribution
About these figures
Every figure here was publicly disclosed by the named company: press releases, annual reports, SEC filings, earnings calls and news coverage. Companies tend to publish their NPS when it is good, so these numbers run higher than a true industry average: read them as what leading companies in this vertical say publicly, not as an industry benchmark.
NPS runs from −100 to +100. Retention figures are reported as the company defines them (net revenue retention, gross revenue retention, customer retention rate, churn). Every entry links to its source in the full database.